Antiviral Potential of Plants against COVID-19 during Outbreaks-An Update
- PMID: 36362351
- PMCID: PMC9655040
- DOI: 10.3390/ijms232113564
Antiviral Potential of Plants against COVID-19 during Outbreaks-An Update
Abstract
Several human diseases are caused by viruses, including cancer, Type I diabetes, Alzheimer's disease, and hepatocellular carcinoma. In the past, people have suffered greatly from viral diseases such as polio, mumps, measles, dengue fever, SARS, MERS, AIDS, chikungunya fever, encephalitis, and influenza. Recently, COVID-19 has become a pandemic in most parts of the world. Although vaccines are available to fight the infection, their safety and clinical trial data are still questionable. Social distancing, isolation, the use of sanitizer, and personal productive strategies have been implemented to prevent the spread of the virus. Moreover, the search for a potential therapeutic molecule is ongoing. Based on experiences with outbreaks of SARS and MERS, many research studies reveal the potential of medicinal herbs/plants or chemical compounds extracted from them to counteract the effects of these viral diseases. COVID-19's current status includes a decrease in infection rates as a result of large-scale vaccination program implementation by several countries. But it is still very close and needs to boost people's natural immunity in a cost-effective way through phytomedicines because many underdeveloped countries do not have their own vaccination facilities. In this article, phytomedicines as plant parts or plant-derived metabolites that can affect the entry of a virus or its infectiousness inside hosts are described. Finally, it is concluded that the therapeutic potential of medicinal plants must be analyzed and evaluated entirely in the control of COVID-19 in cases of uncontrollable SARS infection.
Keywords: COVID-19; MERS; SARS; antiviral; medicinal plants.
Conflict of interest statement
The author declares no conflict of interest.
Figures
Similar articles
-
Phytotherapic Drugs for COVID-19 Treatment: A Scoping Review.Curr Pharm Des. 2021 Oct 5;27(31):3389-3398. doi: 10.2174/1381612827666210705163807. Curr Pharm Des. 2021. PMID: 34225610 Review.
-
Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2.Molecules. 2021 Mar 22;26(6):1775. doi: 10.3390/molecules26061775. Molecules. 2021. PMID: 33809963 Free PMC article. Review.
-
Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.Curr Pharm Biotechnol. 2021;22(4):444-450. doi: 10.2174/1389201021666200703201458. Curr Pharm Biotechnol. 2021. PMID: 32619167 Review.
-
Systematic Review on Major Antiviral Phytocompounds from Common Medicinal Plants against SARS-CoV-2.Med Chem. 2024;20(6):613-629. doi: 10.2174/0115734064262843231120051452. Med Chem. 2024. PMID: 38317467
-
The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection.Nutrients. 2020 Aug 25;12(9):2573. doi: 10.3390/nu12092573. Nutrients. 2020. PMID: 32854262 Free PMC article. Review.
Cited by
-
Myrtucommulones and Related Acylphloroglucinols from Myrtaceae as a Promising Source of Multitarget SARS-CoV-2 Cycle Inhibitors.Pharmaceuticals (Basel). 2024 Mar 28;17(4):436. doi: 10.3390/ph17040436. Pharmaceuticals (Basel). 2024. PMID: 38675398 Free PMC article.
-
In-silico and in-vitro studies to identify potential inhibitors of SARS-CoV-2 spike protein from Omani medicinal plants.Heliyon. 2024 Oct 24;10(21):e39649. doi: 10.1016/j.heliyon.2024.e39649. eCollection 2024 Nov 15. Heliyon. 2024. PMID: 39553680 Free PMC article.
-
Plant-Derived Natural Compounds as an Emerging Antiviral in Combating COVID-19.Indian J Microbiol. 2023 Dec;63(4):429-446. doi: 10.1007/s12088-023-01121-5. Epub 2023 Oct 31. Indian J Microbiol. 2023. PMID: 38031604 Free PMC article. Review.
-
Novel analogues of a nonnucleoside SARS-CoV-2 RdRp inhibitor as potential antivirotics.Beilstein J Org Chem. 2024 May 6;20:1029-1036. doi: 10.3762/bjoc.20.91. eCollection 2024. Beilstein J Org Chem. 2024. PMID: 38746653 Free PMC article.
-
Structural and Functional Characterization of Medicinal Plants as Selective Antibodies towards Therapy of COVID-19 Symptoms.Antibodies (Basel). 2024 May 7;13(2):38. doi: 10.3390/antib13020038. Antibodies (Basel). 2024. PMID: 38804306 Free PMC article.
References
-
- Readhead B., Haure-Mirande J.-V., Funk C.C., Richards M.A., Shannon P., Haroutunian V., Sano M., Liang W.S., Beckmann N.D., Price N.D., et al. Multiscale analysis of independent Alzheimer’s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus. Neuron. 2018;99:64–82.e7. doi: 10.1016/j.neuron.2018.05.023. - DOI - PMC - PubMed
-
- Paraskevis D., Kostaki E.G., Magiorkinis G., Panayiotakopoulos G., Sourvinos G., Tsiodras S. Full-genome evolutionary analysis of the novel Corona virus (2019-ncov) rejects the hypothesis of emergence as a result of a recent recombination event. Infect. Genet. Evol. 2020;79:104212. doi: 10.1016/j.meegid.2020.104212. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous